First Time Loading...

Cumberland Pharmaceuticals Inc
NASDAQ:CPIX

Watchlist Manager
Cumberland Pharmaceuticals Inc Logo
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Watchlist
Price: 1.54 USD -11.49% Market Closed
Updated: May 13, 2024

Balance Sheet

Balance Sheet Decomposition
Cumberland Pharmaceuticals Inc

Current Assets 35.7m
Cash & Short-Term Investments 18.3m
Receivables 9.8m
Other Current Assets 7.6m
Non-Current Assets 46.1m
PP&E 7m
Intangibles 23.5m
Other Non-Current Assets 15.5m
Current Liabilities 28m
Accounts Payable 14m
Accrued Liabilities 348.1k
Other Current Liabilities 13.6m
Non-Current Liabilities 24.2m
Long-Term Debt 12.8m
Other Non-Current Liabilities 11.4m

Balance Sheet
Cumberland Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
40
38
35
45
28
28
25
27
20
18
Cash Equivalents
40
38
35
45
28
28
25
27
20
18
Short-Term Investments
15
15
16
5
8
0
0
0
0
0
Total Receivables
6
6
7
8
8
10
12
7
13
10
Accounts Receivables
6
6
7
8
8
10
12
7
13
10
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
6
4
5
7
12
9
11
8
10
5
Other Current Assets
5
4
3
4
3
3
2
3
3
3
Total Current Assets
71
67
66
69
59
50
50
46
46
36
PP&E Net
1
1
1
1
1
4
3
1
6
7
PP&E Gross
1
1
1
1
1
4
3
1
6
7
Accumulated Depreciation
2
3
3
3
3
3
4
4
2
2
Intangible Assets
22
21
22
21
34
31
28
24
31
23
Goodwill
0
0
0
0
1
1
1
1
1
1
Other Long-Term Assets
2
3
5
3
18
19
15
12
10
15
Other Assets
0
0
0
0
1
1
1
1
1
1
Total Assets
95
N/A
92
-4%
93
+2%
93
0%
113
+21%
105
-7%
97
-8%
84
-12%
93
+10%
82
-12%
Liabilities
Accounts Payable
3
3
8
9
11
12
13
10
11
14
Accrued Liabilities
0
0
0
0
2
3
2
2
2
2
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
11
10
7
9
15
9
10
7
16
12
Total Current Liabilities
14
12
15
18
28
24
26
19
29
28
Long-Term Debt
0
2
4
10
20
19
15
15
16
13
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
1
1
2
9
11
9
8
12
12
Total Liabilities
15
N/A
15
+3%
20
+35%
29
+44%
57
+95%
53
-6%
50
-7%
42
-16%
57
+36%
52
-8%
Equity
Common Stock
62
57
55
52
51
50
49
48
47
47
Retained Earnings
19
20
19
12
5
1
2
6
11
17
Total Equity
81
N/A
77
-5%
73
-5%
64
-12%
56
-13%
51
-8%
47
-8%
43
-9%
36
-15%
30
-18%
Total Liabilities & Equity
95
N/A
92
-4%
93
+2%
93
0%
113
+21%
105
-7%
97
-8%
84
-12%
93
+10%
82
-12%
Shares Outstanding
Common Shares Outstanding
17
16
16
16
16
15
15
15
14
14

See Also

Discover More